{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Northridge",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "87476",
      "recalling_firm": "Medtronic Inc.",
      "address_1": "18000 Devonshire St",
      "address_2": "N/A",
      "postal_code": "91325-1219",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "Worldwide distribution.",
      "recall_number": "Z-1599-2021",
      "product_description": "Medtronic, REF: MMT-7008A, Enlite Glucose Sensor for the following packaging: ENLITE PLUS 5PK 23L 1CL /GTIN: 20643169541706, ENLT PLUS 5PK 2L 1CL PR/ GTIN: 20643169786725, ENLITE PLUS 5PK 23L 1CL/ GTIN: 20763000421292 - Product Usage: intended for use with Medtronic Diabetes (Medtronic) glucose sensing systems to continuously monitor glucose levels in persons with diabetes.",
      "product_quantity": "213,110 units",
      "reason_for_recall": "Use of the continuous glucose monitoring system while actively taking hydroxyurea, an anti-neoplastic drug  could result in inaccurate elevated sensor glucose readings.",
      "recall_initiation_date": "20210226",
      "center_classification_date": "20210517",
      "report_date": "20210526",
      "code_info": "All Lot numbers within active shelf life"
    }
  ]
}